Sarcoidosis: Milestones to the Millennium

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 16, Issue 2, 1999, Pages 174-182

  James, D Geraint ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Combination chemotherapy; Cytokines; Fewer transplants; Granulomatous fibrosis; Millennium; Sarcoidosis

Indexed keywords

4 AMINOBENZOATE POTASSIUM; AZATHIOPRINE; CALCIUM CHELATING AGENT; CELLULOSE PHOSPHATE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; THALIDOMIDE;

CLINICAL FEATURE; FIBROSIS; GRANULOMATOSIS; HISTORY OF MEDICINE; HUMAN; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; TOPICAL DRUG ADMINISTRATION;

ADRENAL CORTEX HORMONES; COMBINED MODALITY THERAPY; CYTOKINES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SARCOIDOSIS;

EID: 0032836729     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. James DG: Descriptive definition and historic aspects of sarcoidosis. Clin Chest Med 1997; 18: 663-679.
2. James DG, Jones Williams W: Sarcoidosis and Other Granulomatous Disorders. W.B. Saunders Company, Philadelphia 1985.
3. Mishra BB, Poulter LW, Janossy G, James DG: The distribution of lymphoid- and macrophage-like subsets of sarcoid and Kveim granulomata: possible mechanisms of negative PPD reactions in sarcoidosis. Clin Exp Immunol 1983; 54: 705-713.
4. Kawakami K, Owan I, Kaneshima H, Saito A: Type 1-like helper T cells in response to autologouos peripheral blood monocytes obtained from bronchoalveolar lavage fluid and affected lymph node of patients with sarcoidosis. Sarcoidosis 1995; 12: 111-117.
5. Roman J, Leon YJ, Gal A, Perez RL: Distribution of extracellular matrices, matrix receptors and Transforming Growth Factor-1 in Human and experimental granulomatous inflammation. Am J Med Sci 1995; 309: 124-133.
6. Reiser H, Stadecker MJ: Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996; 335: 1369-1377.
7. Sharma OP, Neville E, Walker AN, James DG: Familial sarcoidosis: A possible genetic influence. Ann N Y Acad Sci 1976; 278: 386-400.
8. Martinetti M, Tinelli C, Kolek V, et al: "The sarcoidosis map": A joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152: 152-564.
9. Foley PJ, Lympany PA, Welsh KI, du Bois RM: Association between HLA-DRB alleles and sarcoidosis. Abstract P104. Thorax 1998; 53 (suppl. 4) A50.
10. Takemoto Y, Sakatini M, Takami S et al: Association between angiotensin II receptor gene polymorphism and serum angiotensin-converting enzyme (SACE) activity in patients with sarcoidosis. Thorax 1998; 53: 459-162.
11. Ravini M, Ferraro G, Barbieri B, Colombo P, Rizzato G: Changing strategies of lung biopsies in diffuse lung disease: the impact of video-assisted thoracoscopy. Eur Respir J 1998; 11: 99-103.
12. Semenzato G: Chemotactic cytokines: from the molecular level to clinical use. Sarcoidosis Vasc Diff Lung Dis. 1998; 15: 131-133.
13. Iyonaga K, Suga M, Moritaka S, et al: Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 165-172.
14. Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J Med 1998; 338: 436-444.
15. Kodama N, Yamaguchi E, Hizawa N: Expression of RANTES by bronchoalveolar lavage cells in non-smoking patients with interstitial lung disease. Am J Respir Cell Mol Biol 1998; 18: 526-531.
16. Hashimoto S, Nakayama T, Gon Y et al: Correlation of plasma chemoattractant protein-1 (MCP1) and monocyte inflammatory protein-1α levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol 1998; 111: 604-610.
17. Agostini C, Basso V, Semenzato G: Cells and molecules involved in the development of sarcoid granuloma. J Clin Immunol 1998; 18: 184-192.
18. Schall TT, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (Lond) 1990; 347: 669-671.
19. Devergne O, Marfaing-Koka A, Schall TT, et al: Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells. J Exp Med 1994; 179: 1689-1694.
20. Lammi L, Kinmula V, Lohdo S et al: Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Eur Respir J 1997; 10: 2725-2730.
21. James DG and Jones Williams W: Sarcoidosis in The Granulomatous Disorders. Eds. DG James and A Zumla. Cambridge University Press, 1999.
22. James DG: Etiology of Sarcoidosis. In Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York 1994; p 597-617.